Showing 141-150 of 1716 results for "".
ASDS Updates
https://practicaldermatology.com/conferences/asds-2022-annual-meeting/asds-updates/23823/The American Society for Dermatologic Surgery shined in Colorado for the first live annual meeting post pandemic.Teledermatology Use during the COVID-19 Pandemic
https://practicaldermatology.com/columns/clinical-focus-1/teledermatology-use-during-the-covid-19-pandemic/23769/Despite challenges, the future of teledermatology is promising.The Art of Patient Scheduling
https://practicaldermatology.com/topics/practice-management/the-art-of-patient-scheduling/23676/Is your patient scheduling system working as efficiently as possible? Put these five action items in place to ensure your practice is firing on all cylinders.Diversity and Inclusion in Dermatology: The Impact of Systemic Racism in Dermatology and Opportunities for Change
https://practicaldermatology.com/issues/supplements/diversity-and-inclusion-in-dermatology-the-impact-of-systemic-racism-in-dermatology-and-opportunities-for-change/23474/Diversity and Equity in Dermatology
https://practicaldermatology.com/topics/practice-management/diversity-and-equity-in-dermatology/23456/DermWireTV: Pulse's CellFX, Soliton's RAP Technology, Belotero Balance (+), Restylane Defyne, Eczema Costs
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pulses-cellfx-solitons-rap-technology-belotero-balance-restylane-defyne-eczema-costs/19899/The FDA has cleared Pulse Biosciences’ CellFX system, and a commercial rollout will begin soon. There’s another new option for treatment for legs with FDA clearance of Soliton’s Rapid Acoustic Pulse technology for cellulite. For eight percent of Americans with atopic dermatitis, annual out of pocketRecent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-17/23343/Vitiligo: Oral and Topical JAKs Show Promise
https://practicaldermatology.com/topics/pigmentary-disorders/vitiligo-oral-and-topical-jaks-show-promise/23316/Early studies offer some hope for emerging therapies for repigmentation.6 Tools That Can Benefit Every Dermatology Provider
https://practicaldermatology.com/topics/practice-management/6-tools-that-can-benefit-every-dermatology-provider/23283/Whether you’ve never heard of it or simply forgot about it, each of these tools can improve patient care in the clinic.Agminated Pyogenic Granuloma: De Novo Presentations and Review of the Literature
https://practicaldermatology.com/youngmd-connect/resident-resource-center/agminated-pyogenic-granuloma/23221/